Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Phlebitis, Vaccination site pain, Vaccination site warmth
Clinical narrative: Two occurrences of phlebitis in small vessels of index finger of left hand and posterior aspect of right wrist; headache of 3-4 hrs; soreness/warmth at injection site x4 days.; soreness/warmth at injection site x4 days.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date May2021 (Batch/Lot number: unknown) at the age of 37 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Stage IV uterine cancer" (unspecified if ongoing); "PCOS" (unspecified if ongoing); "recurrent migraine" (unspecified if ongoing); "recurrent major depressive disorder" (unspecified if ongoing); "essential HTN" (unspecified if ongoing); "chronic severe widespread MSK pain" (unspecified if ongoing); "Phlebitis" (unspecified if ongoing). Concomitant medication(s) included: MEGESTROL; FLUOXETINE; ASA; PROPRANOLOL; LOSARTAN. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. can't read handwriting on card, Location of injection: Arm Right), administration date: Apr2021, for COVID-19 immunization. The following information was reported: PHLEBITIS (non-serious) with onset Sep2021, outcome "recovered with sequelae", described as "Two occurrences of phlebitis in small vessels of index finger of left hand and posterior aspect of right wrist"; HEADACHE (non-serious) with onset Sep2021, outcome "recovered with sequelae", described as "headache of 3-4 hrs"; VACCINATION SITE PAIN (non-serious), VACCINATION SITE WARMTH (non-serious) all with onset Sep2021, outcome "recovered with sequelae" and all described as "soreness/warmth at injection site x4 days.". Therapeutic measures were taken as a result of headache, vaccination site pain, vaccination site warmth.  Additional information: Patient received second dose at 11:30. It was reported as not a serious, seriousness criteria-results in death, seriousness criteria-life threatening, seriousness criteria-caused/prolonged hospitalization, seriousness criteria-disabling/incapacitating, seriousness criteria-congenital anomaly/birth defect. Reason why batch/lot is Unknown was reported as can't read handwriting on card. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and not tested for COVID-19 since vaccination. No known allergies. Two occurrences of phlebitis in small vessels of index finger of left hand and posterior aspect of right wrist with no known cause. Only other cases of phlebitis in patient history were after insertion of peripheral IVs, which patient have not had since February 2020 and were not inserted in the vessels in question. Side effects in the days following each vaccination included headache of 3-4 hrs and soreness/warmth at injection site x4 days. Treatment reported as warm compresses, ASA for 3 days.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.